Mike Armour

ORCID: 0000-0001-7539-9851 · 127 papers in corpus · active 2017-2026

Study types

  • article 65
  • preprint 31
  • other 20
  • review 5
  • dataset 2

Condition tags

  • endometriosis 118
  • mesh:D004715 38
  • chronic_pelvic_pain 31
  • dysmenorrhea 17
  • mesh:D017699 16
  • dyspareunia 9
  • infertility 7
  • mesh:D004412 4
  • adenomyosis 2
  • bowel_endometriosis 2
other
Complementary therapies in clinical practice ·doi:10.1016/j.ctcp.2024.101839
other 2026
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.70076

There is growing evidence that people with endometriosis are utilising cannabis, whether legally or illicitly procured, for management of pain and associated symptoms. As such, concerns over cannabis use as a medicine are foremost in clinic…

article 2026
Journal of health psychology ·doi:10.1177/13591053251401720

Knowledge pertaining to the interplay between body image, body compassion, and endometriosis-related symptoms is limited. The current study aimed to elucidate the relationships between body compassion, body image, and endometriosis-related …

other 2026
Acta psychologica ·doi:10.1016/j.actpsy.2026.106634

OBJECTIVE: The aim of this study was to examine changes in resting electroencephalography (EEG) activity associated with an 8-week acupuncture intervention for women with endometriosis and chronic pelvic pain. METHODS: Eighteen women aged …

other 2026
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.70073

BACKGROUND: A growing body of evidence suggests that pelvic health physiotherapy is an effective, low-risk management strategy for women with endometriosis and vulvodynia. However, to date no study has identified which interventions Austral…

other 2026
BMC complementary medicine and therapies ·doi:10.1186/s12906-025-05189-y

BACKGROUND: Endometriosis, characterised by the growth of endometrial-like tissue outside the uterus, often causes severe pelvic pain, dysmenorrhea, and fatigue. Current medical treatments frequently provide incomplete symptom control and/o…

article 2026
·doi:10.1186/s12982-026-02018-6

Endometriosis and chronic pelvic pain (CPP) substantially affect work participation and productivity, yet workplace interventions remain largely unevaluated. This study piloted Endo@Work, a co-designed workplace guideline to support employe…

preprint 2025
·doi:10.2139/ssrn.5603451
preprint 2025
·doi:10.21203/rs.3.rs-6910005/v1
rct 2025
Complementary therapies in clinical practice ·doi:10.1016/j.ctcp.2025.102023

BACKGROUND AND PURPOSE: People with endometriosis report consuming cannabis to manage their endometriosis symptoms, however, its efficacy has not been established in clinical studies. This study aimed to determine the feasibility, acceptabi…

other 2025
BMJ open ·doi:10.1136/bmjopen-2024-097872

INTRODUCTION: Endometriosis is a chronic condition affecting up to 11% of people presumed female at birth by the age of 44 years, characterised by the growth of tissue similar to the lining of the uterus on other organs. Endometriosis signi…

preprint 2025
·doi:10.31219/osf.io/23ys9_v1

People with endometriosis in Australia predominantly use delta-9 tetrahydrocannabinol cannabis flower and oil products, and cannabidiol preparations, to manage their symptoms, reporting reductions in use of other drugs. It is known that low…

article 2025
·doi:10.1007/s42212-025-00765-2

Abstract Endometriosis affects various physiological and psychological aspects of sexual life. Around two thirds of patients with endometriosis experience pain during sexual intercourse (dyspareunia), especially those with deep infiltrating…

preprint 2025
·doi:10.20944/preprints202503.0519.v1

Endometriosis costs Australia $9.7 billion AUD annually, with most of the cost burden due to absenteeism and lost productivity. Previous research has shown how the absence of workplace support(s) for endometriosis symptom management exacerb…

article 2025
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare13080930

Background: Endometriosis costs Australia $9.7 billion AUD annually, with absenteeism and lost productivity mostly contributing to this cost burden. Previous research has shown how the absence of workplace support(s) for endometriosis sympt…

article 2025
·doi:10.1080/23293691.2025.2520331
preprint 2025
·doi:10.21203/rs.3.rs-6083910/v1
other 2025
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/ajo.13851

BACKGROUND: Inter-observer agreement for the American Association of Gynecologic Laparoscopists (AAGL) 2021 Endometriosis Classification staging system has not been described. Its predecessor staging system, the revised American Society for…

article 2025
Reproduction & fertility ·doi:10.1530/raf-24-0098

Abstract: People with endometriosis report consuming cannabis to manage their symptoms. Given the range of differing legalities and access pathways across the world, this study aimed to investigate the drivers and barriers to cannabis use w…

other 2025
Journal of pediatric and adolescent gynecology ·doi:10.1016/j.jpag.2024.12.019

STUDY OBJECTIVE: To explore menstrual cycle symptoms, information sources, and menstrual health literacy in young women (age 13-25) and those who menstruate in Aotearoa New Zealand DESIGN AND SETTING: A cross-sectional online survey in Aote…

meta-analysis 2025
Heart (British Cardiac Society) ·doi:10.1136/heartjnl-2024-324675

BACKGROUND: Cardiovascular disease is the leading cause of death globally. Non-malignant gynaecological diseases (NMGD) significantly affect patient health and well-being and may be associated with cardiovascular or cerebrovascular disease …

article 2025
·doi:10.1080/23293691.2025.2556173
review 2025
Expert review of endocrinology & metabolism ·doi:10.1080/17446651.2025.2572339

INTRODUCTION: Endometriosis is a chronic inflammatory condition that affects around 1 in 7 women of reproductive age. Current medical treatments tend to be sub-optimal to manage the range of symptoms, with low levels of patient satisfaction…

article 2025
·doi:10.3390/women5040047

Endometriosis and chronic pelvic pain (CPP) impose substantial economic burden in New Zealand, yet no national cost-of-illness (COI) model currently exists. This study provides the first nationwide estimate using a modified World-Endometrio…

preprint 2025
·doi:10.2139/ssrn.5275523